The Chicago Entrepreneur

Ozempic maker Novo Nordisk to spend $4.1 billion to boost production

Novo Nordisk on Monday said it will invest $4.1 billion in a new Clayton, N.C., manufacturing facility as it works to meet surging demand for its popular injectable drugs Wegovy and Ozempic.

Previous post Bank stocks gain after report about lighter capital requirements
Next post Bitcoin drops below $60k amid fresh sell-off pressure